
The global animal health market is predicted to reach a value of $44.2 billion dollars by 2020, according to analysts …

It’s one of the biggest acquisitions the industry has seen at a total value of $63 billion and after weeks …

Just in time for the NHS’ 70th birthday, UK watchdog NICE has announced that it has taken the decision to …

Biotechnology firm Abivax has lifted the curtain on new Phase 2a data for its HIV therapy ABX464, showing that the …

England’s Chief Medical Officer Dame Sally Davies has concluded that there is “conclusive evidence” that cannabis is medically beneficial for …

The new July/August edition of Pharmafocus is now available to read online.

Researchers from John Hopkins University have developed an experimental drug that slows the progression of Parkinson’s disease in mice. The …

The Broad Institute of MIT and Harvard has expanded its partnership with Bayer through the launch of the Precision Cardiology …

The Danish pharmaceutical company Lundbeck has announced that the company’s Board of Directors have appointed Dr Deborah Dunshire as Lunbeck’s …

Cadila Healthcare has announced that it has gained FDA final approval to market nifedipine ER tablets in the strengths of …

Novartis has penned an agreement with Adamis Pharmaceuticals to commercialise and distribute the latter’s epinephrine auto injector Symjepi in the …

After a campaign full of not-so-veiled threats directed at the pharma industry, and a presidency which has so far failed …

French multinational Sanofi is investing €66 million in a tech-focused operation in China in an effort to increase efficiency and …

Manufacturing of pharmaceuticals takes place all over the world and the health of patients globally is at stake. Ben Hargreaves …

Roche has unveiled new Phase 3 data on its immunotherapy drug Tecentriq (atezolizumab) in combination with chemotherapy (Celgene’s Abraxane) as …